Por favor, tente outra pesquisa
Nome | Idade | Desde | Título |
---|---|---|---|
Harel Gadot | 51 | 2010 | Co-Founder, President, CEO & Chairman |
Eyal Morag | 58 | 2017 | Member of Scientific Advisory Board |
Yoseph Bornstein | 65 | 2010 | Co-Founder & Independent Director |
Scott R. Burell | 59 | 2016 | Independent Director |
Thierry Jacques De Baere | - | 2022 | Member of Scientific Advisory Board |
Gal Yaniv | - | 2022 | Member of Scientific Advisory Board |
Martin J. Madden | 63 | 2017 | Independent Director |
Tal Baruch Wenderow | 49 | 2020 | Independent Director |
David C. Madoff | - | 2022 | Member of Scientific Advisory Board |
Prattipati Laxminarain | 66 | 2017 | Independent Director |
Francois H. Cornelis | - | 2023 | Member of Scientific Advisory Board |
Ziv Neeman | - | 2022 | Member of Scientific Advisory Board |
Ripal T. Gandhi | - | 2022 | Member of Scientific Advisory Board |
Giora Weisz | - | 2022 | Member of Scientific Advisory Board |
Gerry O'Sullivan | - | 2023 | Member of Scientific Advisory Board |
Aileen Ptucha Stockburger | 61 | 2020 | Independent Director |
Francisco C. Carnevale | - | 2023 | Member of Scientific Advisory Board |
Mark W. Little | - | 2023 | Member of Scientific Advisory Board |
Clare Bent | - | - | Member of Scientific Advisory Board |
Vincent Vidal | - | 2022 | Member of Scientific Advisory Board |
Dmitry J. Rabkin | - | 2022 | Member of Scientific Advisory Board |
Ajay K. Wakhloo | - | 2022 | Member of Scientific Advisory Board |
Sebastian Flacke | - | 2022 | Member of Scientific Advisory Board |
Stephen B. Solomon | - | 2022 | Member of Scientific Advisory Board |
Irene Bargellini | - | - | Member of Scientific Advisory Board |
Stavros Spiliopoulos | - | 2023 | Member of Scientific Advisory Board |
Quer mesmo bloquear %USER_NAME%?
Se o fizer, não poderá consultar as mensagens de %USER_NAME% e vice versa em Investing.com.
Adicionou %USER_NAME% com sucesso à sua Lista de Bloqueios
Uma vez que acabou de desbloquear esta pessoa, deve aguardar 48 horas antes de bloqueá-la novamente.
Diga-nos o que achou deste comentário
Obrigado!
Seu comentário foi enviado aos moderadores para revisão